The Impact of Statin Type on Hepatocellular Carcinoma Risk

https://www.jwatch.org/na49747/2019/08/22/impact-statin-type-hepatocellular-carcinoma-risk

In patients with chronic viral hepatitis, only lipophilic statin use, and not hydrophilic statin use, significantly lowered 10-year HCC risk.

Ryan
Ryan

No Comments

Write a Reply or Comment